Ladenburg Thalmann Financial Services’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CPXX Stock Details CPXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-600	Closed	-$18K	–	5045
2016 Q2	$18K	Hold	600	–	–	﹤0.01%	3433
2016 Q1	$7K	Buy	+600	New	+$1.97K	﹤0.01%	3939

Ladenburg Thalmann Financial Services's CPXX Position: Q3 2016 in Review

Ladenburg Thalmann Financial Services sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 600 shares — an estimated $18K sold.

Ladenburg Thalmann Financial Services first reported a position in CPXX in Q1 2016 and held it in 2 quarters. The position peaked at $18K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

Ladenburg Thalmann Financial Services reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 600 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $18K.
Ladenburg Thalmann Financial Services first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q1 2016 and held it in 2 quarters.
Ladenburg Thalmann Financial Services's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $18K in Q2 2016.
0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2016, filed 14 Nov 2016.